# Dopaminergic Enhancement of Learning and Memory in Aphasia

> **NCT00102869** · PHASE4 · COMPLETED · sponsor: **University Hospital Muenster** · enrollment: 12 (actual)

## Conditions studied

- Cerebrovascular Accident
- Aphasia

## Interventions

- **DRUG:** levodopa

## Key facts

- **NCT ID:** NCT00102869
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-02
- **Final completion:** 2008-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00102869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00102869, "Dopaminergic Enhancement of Learning and Memory in Aphasia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00102869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*